SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiopharma Cred. Regulatory News (BPCR)

Share Price Information for Biopharma Cred. (BPCR)

Share Price is delayed by 15 minutes
Get Live Data
0.944    0.00 (0.00%)
Bid:
0.944
Ask:
0.946
Spread: 0.002 (0.212%)
Market Cap: $1.06b
BPCR Live PriceLast checked at - London Stock Exchange

Intraday Biopharma Cred. Share Chart

Transaction in Own Shares

3 Apr 2025 18:15

RNS Number : 6160D
BioPharma Credit PLC
03 April 2025
 

BioPharma Credit plc

(the "Company")

TRANSACTION IN OWN SHARES

 

BioPharma Credit PLC announces that today it has purchased the following number of its ordinary shares of US $0.01 each through J.P. Morgan Securities plc into treasury.

 

 

Ordinary Shares: BPCR LN

Date of purchase: 3 April 2025

Number of ordinary shares purchased: 500,000

Lowest price per share: $0.8700

Highest price per share: $0.8700

Trading venue: JPMSI

 

 

Ordinary Shares: BPCR LN

Date of purchase: 3 April 2025

Number of ordinary shares purchased: 50,000

Lowest price per share: $0.8700

Highest price per share: $0.8700

Trading venue: LSE

 

 

Aggregate volume per date per trading venue: 550,000

Weighted average price per day per trading venue: $0.8737

 

Following the above transaction, the Company holds 244,207,072 of its ordinary shares in treasury and has 1,129,724,995 ordinary shares in issue (excluding treasury shares). Therefore, the total number of voting rights in the Company is 1,129,724,995. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

 

Enquiries:

BioPharma Credit plc

via MUFG Corporate Governance Limited

Company Secretary

+44 (0) 333 300 1932

Burson Buchanan

Mark Court / Jamie Hooper / Henry Wilson / Samuel Adams

+44 (0)20 7466 5000

biopharmacredit@buchanan.uk.com

 

Notes to Editors:

 

BioPharma Credit PLC is London's only specialist debt investor to the life sciences industry and joined the LSE in March 2017. BioPharma Credit PLC seeks to provide long-term shareholder returns, principally in the form of sustainable income distributions from exposure to the life sciences industry. BioPharma Credit PLC seeks to achieve this objective primarily through investments in debt assets secured by royalties or other cash flows derived from the sales of approved life sciences products.

 

 

LEI: 213800AV55PYXAS7SY24

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSQXLFBEZLLBBE
Date   Source Headline
20th Apr 20227:00 amRNSProposed Secondary Placing in BioPharma Credit Plc
22nd Mar 20227:00 amRNSAnnual Financial Report
21st Mar 20224:00 pmRNSNet Asset Value(s) and Monthly Factsheet
10th Mar 20222:17 pmRNSNOTICE OF FULL YEAR RESULTS
8th Mar 20224:30 pmRNSNEW INVESTMENT
24th Feb 20223:58 pmRNSDividend Declaration
21st Feb 20224:00 pmRNSNet Asset Value(s) and Monthly Factsheet
18th Feb 20224:37 pmRNSDirector/PDMR Shareholding
14th Feb 202212:30 pmRNSUS$325 MILLION INVESTMENT IN COLLEGIUM
24th Jan 20224:00 pmRNSNet Asset Value(s) and Monthly Factsheet
10th Jan 20227:00 amRNSNEW INVESTMENT OF UP TO US$150.0 MILLION
21st Dec 20214:00 pmRNSNet Asset Value(s) and Monthly Factsheet
15th Dec 20217:00 amRNSNEW INVESTMENTS OF UP TO US$112.5 MILLION
19th Nov 20214:00 pmRNSNet Asset Value(s) and Monthly Factsheet
4th Nov 20217:00 amRNSDividend Declaration
21st Oct 20214:00 pmRNSNet Asset Value(s) and Monthly Factsheet
11th Oct 202111:39 amRNSDirector Declaration
8th Oct 20217:00 amRNSConfirmation of Delisting from TISE
5th Oct 20217:00 amRNSTransfer of Shares to the Premium Segment
30th Sep 20214:30 pmRNSResult of General Meeting
21st Sep 20214:00 pmRNSNet Asset Value(s) and Monthly Factsheet
15th Sep 20217:00 amRNSHalf-yearly Report
13th Sep 20217:29 amRNSCREDIT FACILITY UPDATE
27th Aug 20215:30 pmRNSHolding(s) in Company
26th Aug 20215:00 pmRNSHolding(s) in Company
25th Aug 20217:00 amRNSNotice of Half Year Results
20th Aug 20214:00 pmRNSNet Asset Value(s)
19th Aug 20215:30 pmRNSDirector/PDMR Shareholding
12th Aug 20217:00 amRNSDividend Declaration
10th Aug 20214:45 pmRNSHolding(s) in Company
21st Jul 20214:00 pmRNSNet Asset Value(s) and Monthly Factsheet
24th Jun 20211:30 pmRNSResult of GM and AGM
21st Jun 20214:00 pmRNSNet Asset Value(s) and Monthly Factsheet
17th Jun 20213:30 pmRNSResult of Annual General Meeting
4th Jun 20214:30 pmRNSNotice of GM and Change in Proposed Auditor
26th May 20214:00 pmRNSDividend Declaration
25th May 20213:45 pmRNSChange of Auditor
25th May 20213:30 pmRNSNotice of AGM
24th May 20214:00 pmRNSNet Asset Value(s) and Monthly Factsheet
6th May 202110:30 amRNSDirector/PDMR Shareholding
23rd Apr 20214:00 pmRNSNet Asset Value(s) and Monthly Factsheet
12th Apr 202111:00 amRNSHolding(s) in Company
24th Mar 20217:00 amRNSNEW INVESTMENT
19th Mar 20214:00 pmRNSNet Asset Value(s) and Monthly Factsheet
16th Mar 20217:00 amRNSAnnual Financial Report
12th Mar 20215:00 pmRNSReplacement: Dividend Declaration
11th Mar 20215:15 pmRNSDividend Declaration
19th Feb 20214:00 pmRNSNet Asset Value(s) and Monthly Factsheet
17th Feb 20217:00 amRNSNotice of Full Year Results
22nd Jan 20214:00 pmRNSNet Asset Value(s) and Monthly Factsheet

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.